X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs SANOFI INDIA - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE SANOFI INDIA CADILA HEALTHCARE/
SANOFI INDIA
 
P/E (TTM) x 35.1 30.0 117.1% View Chart
P/BV x 9.0 5.3 170.8% View Chart
Dividend Yield % 0.7 1.7 39.7%  

Financials

 CADILA HEALTHCARE   SANOFI INDIA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-16
SANOFI INDIA
Dec-16
CADILA HEALTHCARE/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs4544,560 10.0%   
Low Rs3054,400 6.9%   
Sales per share (Unadj.) Rs96.11,028.5 9.3%  
Earnings per share (Unadj.) Rs14.9129.0 11.5%  
Cash flow per share (Unadj.) Rs17.8186.0 9.6%  
Dividends per share (Unadj.) Rs3.2068.00 4.7%  
Dividend yield (eoy) %0.81.5 55.6%  
Book value per share (Unadj.) Rs52.3753.6 6.9%  
Shares outstanding (eoy) m1,023.7423.03 4,445.2%   
Bonus/Rights/Conversions FV5:1--  
Price / Sales ratio x3.94.4 90.7%   
Avg P/E ratio x25.534.7 73.4%  
P/CF ratio (eoy) x21.324.1 88.4%  
Price / Book Value ratio x7.35.9 122.1%  
Dividend payout %21.552.7 40.8%   
Avg Mkt Cap Rs m388,458103,174 376.5%   
No. of employees `00015.43.6 426.2%   
Total wages/salary Rs m13,3173,592 370.7%   
Avg. sales/employee Rs Th6,371.16,537.7 97.5%   
Avg. wages/employee Rs Th862.4991.4 87.0%   
Avg. net profit/employee Rs Th986.1819.8 120.3%   
INCOME DATA
Net Sales Rs m98,37623,686 415.3%  
Other income Rs m941708 132.9%   
Total revenues Rs m99,31724,394 407.1%   
Gross profit Rs m23,8295,281 451.2%  
Depreciation Rs m3,0221,313 230.2%   
Interest Rs m48615 3,240.0%   
Profit before tax Rs m21,2624,661 456.2%   
Minority Interest Rs m-3000-   
Prior Period Items Rs m50-   
Extraordinary Inc (Exp) Rs m-250-   
Tax Rs m5,7161,691 338.0%   
Profit after tax Rs m15,2262,970 512.7%  
Gross profit margin %24.222.3 108.6%  
Effective tax rate %26.936.3 74.1%   
Net profit margin %15.512.5 123.4%  
BALANCE SHEET DATA
Current assets Rs m44,37615,673 283.1%   
Current liabilities Rs m34,0716,678 510.2%   
Net working cap to sales %10.538.0 27.6%  
Current ratio x1.32.3 55.5%  
Inventory Days Days5476 70.9%  
Debtors Days Days6222 279.4%  
Net fixed assets Rs m47,8968,098 591.5%   
Share capital Rs m1,024230 444.6%   
"Free" reserves Rs m48,74617,088 285.3%   
Net worth Rs m53,51917,356 308.4%   
Long term debt Rs m8,9640-   
Total assets Rs m100,16325,400 394.3%  
Interest coverage x44.7311.7 14.4%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.00.9 105.3%   
Return on assets %15.711.8 133.5%  
Return on equity %28.417.1 166.3%  
Return on capital %34.326.9 127.3%  
Exports to sales %45.324.5 184.9%   
Imports to sales %5.928.0 21.2%   
Exports (fob) Rs m44,5375,801 767.7%   
Imports (cif) Rs m5,8386,627 88.1%   
Fx inflow Rs m44,8817,145 628.1%   
Fx outflow Rs m9,0696,846 132.5%   
Net fx Rs m35,812299 11,977.3%   
CASH FLOW
From Operations Rs m19,9383,226 618.0%  
From Investments Rs m-9,039-1,555 581.3%  
From Financial Activity Rs m-9,527-1,818 524.0%  
Net Cashflow Rs m1,372-147 -933.3%  

Share Holding

Indian Promoters % 74.8 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 8.3 14.4 57.6%  
FIIs % 5.9 14.6 40.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 10.5 104.8%  
Shareholders   44,069 15,184 290.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   ALKEM LABORATORIES  PLETHICO PHARMA  GLENMARK PHARMA  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Aug 21, 2017 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - ALEMBIC LTD COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS